Nu-Med Plus, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUMD research report →
Companywww.nu-medplus.com
Nu-Med Plus, Inc. , a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications.
- CEO
- William R. Colvin
- IPO
- 2014
- Employees
- 2
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $852.19K
- P/E
- -16.35
- P/S
- 0.00
- P/B
- -2.97
- EV/EBITDA
- -22.36
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 19.60%
- ROIC
- 26.36%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-56,182 · 17.80%
- EPS
- $-0.00 · 12.50%
- Op Income
- $-48,955
- FCF YoY
- -982.31%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- -1.85
- Avg Volume
- 13.72K
Get TickerSpark's AI analysis on NUMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 1, 15 | MERRELL KEITH L | other | 0 |
| Nov 7, 23 | Robins Jeffrey Lynn | other | 200,000 |
| Nov 7, 23 | HAYDE WILLIAM C | other | 1,000,000 |
| Sep 12, 22 | HAYDE WILLIAM C | other | 0 |
| Mar 2, 21 | Smith Wendy P. | other | 0 |
| Mar 2, 21 | Smith Wendy P. | other | 0 |
| Aug 5, 16 | Morrison Craig | other | 2,000,000 |
| Apr 23, 15 | Earl Brett J. | other | 800,000 |
| Jan 26, 15 | Christensen Mark Edward | other | 0 |
| Jan 26, 15 | Earl Brett J. | other | 0 |
Our NUMD Coverage
We haven't published any research on NUMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NUMD Report →